Paid Clinical Trials in Huntington, WV
As of July 2026, 48 paid clinical trials are recruiting in Huntington, West Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Huntington offers studies at sites including Edwards Comprehensive Cancer Center for conditions such as Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Opioid Use Disorder, Recurrent Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Huntington
Trials by drug in Huntington
Filter results
48 clinical trials
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
SuperSaturated Oxygen Comprehensive Observational Registry
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Project: Every Child for Younger Patients With Cancer
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Top Research Study Locations in Huntington
Researchers run research studies in Huntington, WV at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Edwards Comprehensive Cancer Center | Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 27 |
| Marshall Health | Chronic Migraine, Headache, Headache Disorders | 4 |
| Marshall University Medical Center | Anastomotic Leaks, Chronic Migraine in Children, Hartmanns Stump Leakage | 3 |
| Huntington VA Medical Center, Huntington, WV | Atherosclerosis, Metformin, Opioid Use Disorder | 2 |
| Saint Mary's Medical Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage HER2+ Breast Cancer | 2 |
| University Physicians and Surgeons Inc, dba Marshall Health | Moderately to Severely Active Crohns Disease, Primary Biliary Cholangitis (PBC) | 2 |
| Cabell Huntington Hospital | Lumbar Spinal Stenosis | 1 |
| Marshall Health Clinical Research Center | Chronic Migraine, Episodic Migraine | 1 |
| Marshall University | Anterior Cruciate Ligament Rupture | 1 |
| Marshall University Division of Addiction Sciences P.R.O.A.C.T | Opioid Use Disorder | 1 |
| Marshall University Joan C. Edwards School of Medicine | Treatment Resistant Depression | 1 |
| Maternal Hypertension Center at Cabell Huntington Hospital | Cardiac Output, High, Cardiac Output, Low, Diastolic Hypertension | 1 |
| Ohio State University Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
| St Mary's Medical Center | AMI, STEMI - ST Elevation Myocardial Infarction | 1 |
| St Marys Med Ctr | Lumbar Spinal Stenosis | 1 |
| St. Mary's Medical Center | Arteriovenous Malformation of Central Nervous System, Neoplasms, Trigeminal Neuralgia | 1 |
| Upsher-Smith Clinical Trial | Migraine Disorders | 1 |
Active & Upcoming Studies in Huntington (2026)
Recruiting trials in Huntington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (26 active studies)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
- A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations · Phase 2 · Sameek Roychowdhury
Neurology & pain (5 active studies)
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults · Phase 2 · Ipsen
- Responding With Evidence and Access for Childhood Headaches · Children's Hospital Medical Center, Cincinnati
Cardiovascular (2 active studies)
Mental health & behavior (1 active study)
Pediatric (1 active study)
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine · Phase 3 · H. Lundbeck A/S
Common conditions studied in Huntington
- Lung Non-Small Cell Carcinoma (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Opioid Use Disorder (3 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies)
- Stage IIIB Lung Cancer AJCC v8 (3 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Huntington
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- SWOG Cancer Research Network
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntington?
There are approximately 48 recruiting clinical trials in Huntington, West Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntington pay participants?
Most recruiting trials in Huntington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntington?
The most common conditions under active study in Huntington include Lung Non-Small Cell Carcinoma (4), Stage IV Lung Cancer AJCC v8 (4), Opioid Use Disorder (3), Recurrent Lung Non-Small Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntington?
Recruiting research sites in Huntington include Edwards Comprehensive Cancer Center, Marshall Health, Marshall University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntington right now?
The largest active categories in Huntington are Cancer & tumors (26), Neurology & pain (5), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.